F&P Healthcare's (FPH) 1H23 result confirmed the worst of the COVID crunch is over; the result itself was solid without being spectacular and modestly ahead of our expectations, driven by higher revenue (aided by FX benefits)
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.